000739:SHE
Apeloa Pharmaceutical Co Ltd
23,42Â CNÂ¥
arrow_downward
-1,64%(-0,39) 1D
16 tet, 3:04:48 m.d., GMT+8 · CNY
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për 000739...
Hap
24,04Â CNÂ¥
I lartë
24,76Â CNÂ¥
I ulët
23,09Â CNÂ¥
Kapitalizimi i tregut
27,13Â mld
Vëllimi mesatar
16,27Â mln
Vëllimi
15,09Â mln
Dividendi
1,61%
Dividendi tremujor
0,09Â CNÂ¥
Data e ndërprerjes së dividendit
8 tet 2026
Raporti çmim/fitim
31,78
Maksimumi 52-javor
28,50Â CNÂ¥
Minimumi 52-javor
14,89Â CNÂ¥
Fitimet për aksion
0,74Â CNÂ¥
Aksionet në qarkullim
1,16Â mld
Numri i punonjësve
7 mijë
Hap
24,04Â CNÂ¥
I lartë
24,76Â CNÂ¥
I ulët
23,09Â CNÂ¥
Kapitalizimi i tregut
27,13Â mld
Vëllimi mesatar
16,27Â mln
Vëllimi
15,09Â mln
Dividendi
1,61%
Dividendi tremujor
0,09Â CNÂ¥
Data e ndërprerjes së dividendit
8 tet 2026
Raporti çmim/fitim
31,78
Maksimumi 52-javor
28,50Â CNÂ¥
Minimumi 52-javor
14,89Â CNÂ¥
Fitimet për aksion
0,74Â CNÂ¥
Aksionet në qarkullim
1,16Â mld
Numri i punonjësve
7 mijë
Aksionet e lidhura
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Bloomberg.com
·
49 minuta më parë
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Yahoo Finance
·
13 orë më parë
Michael Burry Warns of a Stock Market ‘Supervolcano’
MarketWatch
·
8 orë më parë
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Seeking Alpha
·
2 orë më parë
SH: A Tactical Hedge, But Not Yet A Short Call (NYSEARCA:SH)
Profili
Apeloa Pharmaceutical Co., Ltd., known as Apeloa, is a Chinese pharmaceutical manufacturer under Hengdian Group. The company is headquartered in Hengdian, Dongyang, Zhejiang, China. It was founded in 1989 and has been listed on the Shenzhen Stock Exchange since 9 May 1997. Apeloa provides contract development and manufacturing services and manufactures APIs and finished dosage forms; products span cardiovascular, anti-infective, psychiatric and oncology areas.
Apeloa has 7400 employees, 8 manufacturing sites and 3 R&D centers in Boston, Shanghai and Hengdian, covering flow chemistry, synthetic biology and biocatalysis, and peptide development. It has invested over USD20 million in flow chemistry over the past ten years in an effort to advance sustainable pharmaceutical manufacturing. In Boston, its 17,000-square-foot facility does R&D related to chemistry needs in drug development, including preclinical chemistry, scale-up production and new drug development.
Apeloa Pharmaceutical has successfully passed 20 U.S. FDA inspections since 2006. Wikipedia
Rreth Apeloa Pharmaceutical Co Ltd